Shi X - Search Results

1

A Pharmacogenomic Landscape in Human Liver Cancers.

Qiu Z, Li H, Zhang Z, Zhu Z, He S, Wang X, Wang P, Qin J, Zhuang L, Wang W, Xie F, Gu Y, Zou K, Li C, Li C, Wang C, Cen J, Chen X, Shu Y, Zhang Z, Sun L, Min L, Fu Y, Huang X, Lv H, Zhou H, Ji Y, Zhang Z, Meng Z, Shi X, Zhang H, Li Y, Hui L. Qiu Z, et al. Among authors: shi x. Cancer Cell. 2019 Aug 12;36(2):179-193.e11. doi: 10.1016/j.ccell.2019.07.001. Epub 2019 Aug 1. Cancer Cell. 2019. PMID: 31378681 Free PMC article.

2

miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Mu W, Hu C, Zhang H, Qu Z, Cen J, Qiu Z, Li C, Ren H, Li Y, He X, Shi X, Hui L. Mu W, et al. Among authors: shi x. Cell Res. 2015 Apr;25(4):477-95. doi: 10.1038/cr.2015.23. Epub 2015 Feb 20. Cell Res. 2015. PMID: 25698578 Free PMC article.

3

Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.

Shi XL, Gao Y, Yan Y, Ma H, Sun L, Huang P, Ni X, Zhang L, Zhao X, Ren H, Hu D, Zhou Y, Tian F, Ji Y, Cheng X, Pan G, Ding YT, Hui L. Shi XL, et al. Cell Res. 2016 Feb;26(2):206-16. doi: 10.1038/cr.2016.6. Epub 2016 Jan 15. Cell Res. 2016. PMID: 26768767 Free PMC article.

4

Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy.

Li J, Wu PW, Zhou Y, Dai B, Zhang PF, Zhang YH, Liu Y, Shi XL. Li J, et al. Cell Death Dis. 2018 Feb 14;9(2):225. doi: 10.1038/s41419-018-0329-z. Cell Death Dis. 2018. PMID: 29445087 Free PMC article.

5

Human endoderm stem cells reverse inflammation-related acute liver failure through cystatin SN-mediated inhibition of interferon signaling.

Xu Y, Wang J, Ren H, Dai H, Zhou Y, Ren X, Wang Y, Feng S, Deng X, Wu J, Fu T, Nie T, He H, Wei T, Zhu B, Hui L, Li B, Wang J, Wang H, Chen L, Shi X, Cheng X. Xu Y, et al. Among authors: shi x. Cell Res. 2023 Feb;33(2):147-164. doi: 10.1038/s41422-022-00760-5. Epub 2023 Jan 20. Cell Res. 2023. PMID: 36670290 Free PMC article.

6

USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.

Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang W, Guan W, Zhou J, Wu Y, Qiu Y, Ding Y. Yuan X, et al. Among authors: shi x. Oncol Rep. 2015 Aug;34(2):823-32. doi: 10.3892/or.2015.4065. Epub 2015 Jun 15. Oncol Rep. 2015. PMID: 26081192

7

Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.

Wang H, Wang J, Shi X, Ding Y. Wang H, et al. Among authors: shi x. J BUON. 2017 Nov-Dec;22(6):1517-1524. J BUON. 2017. PMID: 29332347 Free article.

8

Lipometabolism and Glycometabolism in Liver Diseases.

Ding HR, Wang JL, Ren HZ, Shi XL. Ding HR, et al. Biomed Res Int. 2018 Dec 12;2018:1287127. doi: 10.1155/2018/1287127. eCollection 2018. Biomed Res Int. 2018. PMID: 31205932 Free PMC article. Review.

9

Hepatic spheroids derived from human induced pluripotent stem cells in bio-artificial liver rescue porcine acute liver failure.

Chen S, Wang J, Ren H, Liu Y, Xiang C, Li C, Lu S, Shi Y, Deng H, Shi X. Chen S, et al. Among authors: shi y, shi x. Cell Res. 2020 Jan;30(1):95-97. doi: 10.1038/s41422-019-0261-5. Epub 2019 Dec 11. Cell Res. 2020. PMID: 31827240 Free PMC article. No abstract available.

10

Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.

Zhu ZY, Tang N, Wang MF, Zhou JC, Wang JL, Ren HZ, Shi XL. Zhu ZY, et al. Front Immunol. 2022 Jan 5;12:781087. doi: 10.3389/fimmu.2021.781087. eCollection 2021. Front Immunol. 2022. PMID: 35069553 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,347 results

Search Page